G. Michael Wall
Plus aucun poste en cours
Profil
G.
Michael Wall worked as a Vice President-Product Development at Otonomy, Inc. before pursuing his education.
He holds a graduate degree from Auburn University and a doctorate from the University of Mississippi.
Anciens postes connus de G. Michael Wall
| Sociétés | Poste | Fin |
|---|---|---|
| OTONOMY | Corporate Officer/Principal | - |
Formation de G. Michael Wall
| University of Mississippi | Doctorate Degree |
| Auburn University | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
